Cromos Pharma is a US based international contract research organization

insights

News

Clinical Trial Success Starts with an Airtight Protocol

22 May 2023

A well-designed clinical trial protocol is paramount to ensuring the success of a clinical trial, and therefore, should be approached with utmost consideration. Protocols are more than just instruction manuals; they are multifunctional and detailed roadmaps that are the core mechanism for translating a brilliant idea into an effective clinical trial. When writing a protocol, it is important to carefully consider its key objectives, from scientific methodology to patient safety parameters...

Clinical Trials Day 2023

19 May 2023

May 20th is Clinical Trials Day. This special day serves as a reminder of the invaluable contributions made by researchers, healthcare professionals, and study participants in advancing medical research. Their dedication and commitment to improving healthcare outcomes are commendable. Let us celebrate the progress made through clinical trials and look forward to a future of continued innovation and breakthroughs! Clinical Trials Day commemorates the date when Dr. James Lind, a naval surgeon...

FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance

09 May 2023

On May 2, 2023, the U.S. Food and Drug Administration (FDA) has issued a novel Draft Guidance to further support the use of decentralized clinical trials (DCTs) for drugs, biological products, and devices. This guidance has recommendations for sponsors, investigators and other industry stakeholders regarding the implementation of DCTs to advance medical product development and research. DCTs are clinical trials where some or all trial-related activities occur at locations other than...

Revision of the EU Pharmaceutical Legislation: the Changes Are Major and the Impact Will Be Significant

28 Apr 2023

On April 24, 2023, in its first major revision of the EU pharmaceutical legislation in over 20 years the Commission is proposing the most ambitious changes that will have a lasting impact on the drug industry. The reform includes two legislative proposals: a new Directive and a new Regulation which establish the EU regulatory framework for all medicines, replacing the previous pharmaceuticals legislation. Here are the important highlights: 1. In a push to create equal access to medicines...

Key Takeaways from AACR Annual Meeting 2023

28 Apr 2023

Cromos Pharma’s Chief Operating Officer, Stephanie Finnegan, recently attended the AACR Annual Meeting, on April 14-19 in Orlando, FL. She took part in discussions with key opinion leaders about current preclinical and clinical research trends and held a significant number of meetings with Sponsors to discuss their development program plans and challenges. Stephanie’s key takeaways from this year’s AACR: The fight against cancer requires a collaborative effort across many different...

Cromos Pharma Appoints Elçin Gulistanoglu as New Head of Operations in Türkiye

19 Apr 2023

Elçin is an experienced clinical research professional with a career spanning over 20 years. Her extensive knowledge in multiple therapeutic areas, including oncology, adult and pediatric endocrinology, vaccinology and rheumatology makes her a welcome addition to Cromos Pharma’s highly professional team. Elçin has held a variety of senior clinical development positions in the leading international pharmaceutical companies such AstraZeneca, Sanofi and Pfizer. Most recently she enjoyed the...

Meet Cromos Pharma at the Clinical Trials Nexus Conference!

18 May 2023

Cromos Pharma will be participating in the Clinical Trials Nexus Conference, which is set to take place June 15-16, 2023 in Amsterdam. Cromos Pharma’s CEO Vlad Bogin, MD, FACP is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. Clinical Trials Nexus is a conference that brings together key decision-makers and senior clinical trials...

Meet Cromos Pharma at the BIO International Convention 2023!

11 May 2023

Cromos Pharma’s CEO Vlad Bogin, MD, FACP, and US Business Development Director, Nicole Brenna, are delighted to be taking part in the BIO International Convention, June 5-8 in Boston, MA. It’s always an event that delivers featuring presentations from leading pharma and biotech players. We are looking forward to sharing with you our experience and expertise in managing all aspects of clinical trials and how our solutions accelerate the drug development process. Reach out to us directly...

Meet Cromos Pharma at the ASCO Annual Meeting!

04 May 2023

We at Cromos Pharma are looking forward to learning about the latest advances in oncology research at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) that will take place on June 2-6 in Chicago, IL. Vlad Bogin, Cromos Pharma’s CEO will be attending. Meet him in person or set up a virtual call by emailing inquiry@cromospharma.com. About Cromos Pharma Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical...

World Orphan Drug Congress, conference 2023, congress 2023

Meet Cromos Pharma at World Orphan Drug Congress 2023!

21 Apr 2023

Cromos Pharma is delighted to be taking part in World Orphan Drug Congress 2023 which will take place May 23-25 in Washington D.C. Nicole Brenna, US Business Development Director, is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government...

Meet Cromos Pharma at AACR Annual Meeting 2023!

21 Mar 2023

We are pleased to announce that our Chief Operating Officer, Stephanie Finnegan, will be participating in the upcoming AACR Annual Meeting to be held on April 14 – 19 at Orlando, Florida. As a leading provider of clinical research services, we look forward to engaging with healthcare professionals and stakeholders to discuss the latest advancements in cancer studies and explore potential collaborations. The AACR Annual Meeting serves as the hub of the cancer research community, bringing...

clinical research conference, SCOPE 2023 in Orlando, FL, Cromos Pharma

Meet Cromos Pharma at SCOPE 2023!

23 Jan 2023

Cromos Pharma is delighted to be taking part in SCOPE Summit 2023 which will take place February 6-9 in Orlando, FL. Nicole Brenna, US Business Development Director, is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. About Cromos Pharma Cromos Pharma is a US-based, international contract research organization delivering fully...

Clinical Trials in the Baltic States – Countries’ Profile for 2023

25 May 2023

In recent years the Baltic States, comprised of Estonia, Latvia and Lithuania, have become a formidable destination for conducting clinical trials due to its mature healthcare systems and rational regulatory reforms. On the one hand, the Baltic states abide by the same international standards and agreements as other EU countries, and, on the other, the low cost of living and affordable clinical trial services make the Baltic States very attractive for clinical stage biopharmaceutical...

FDA's RTOR Program, FDA Real-Time Oncology Review

The Pros and Cons of the FDA’s Real-Time Oncology Review Program

16 May 2023

The FDA’s Real-Time Oncology Review (RTOR) is a novel program designed to expedite the review of new cancer therapies. Since its inception the program has gained considerable attention among biotech professionals, especially those working in the field of oncology. Under the RTOR program, the FDA accepts data from clinical trials in real-time and reviews them as they become available. The program aims to accelerate the review process for new cancer therapies by allowing the FDA to review data...

Clinical Research Focus. 16th Edition

02 May 2023

Clinical Trials in Hungary Hungary is known for its well-developed regulatory environment and advanced healthcare system. This has made the country a popular destination for pharmaceutical companies and contract research organizations (CROs) to conduct their clinical trials. Aligned with the European Union regulations, the approval process for clinical trials is streamlined and efficient, significantly reducing the timelines for starting new trials. Consequently, there are currently 1,044...

Clinical Trials in Hungary – Country Profile for 2023

26 Apr 2023

Hungary is known for its well-developed regulatory environment and advanced healthcare system. This has made the country a popular destination for pharmaceutical companies and contract research organizations (CROs) to conduct their clinical trials. Aligned with the European Union regulations, the approval process for clinical trials is streamlined and efficient, significantly reducing the timelines for starting new trials. Consequently, there are currently 1044 clinical trials being conducted...

Clinical Research Focus. 15th Edition

04 Apr 2023

Clinical Trials in Bulgaria – Country Profile for 2023 Bulgaria, located in Southeastern Europe, boasts a mature healthcare system and a growing pharmaceutical industry. Based on the significant number of clinical trials conducted per capita, Bulgaria is recognized as one of Europe’s formidable clinical research hubs. There are currently 550 clinical trials being conducted in the country, acting as a further incentive to the Bulgarian Association of Clinical Research (BACR) to advocate for...

Clinical Trials in Bulgaria – Country Profile for 2023

29 Mar 2023

Bulgaria, located in Southeastern Europe, boasts a mature healthcare system and a growing pharmaceutical industry. Based on the significant number of clinical trials conducted per capita, Bulgaria is recognized as one of Europe’s formidable clinical research hubs. With around 12,000 patients enrolled annually, Bulgaria is an attractive proposition for pharmaceutical companies and CROs. There are currently 550 clinical trials being conducted in the country, acting as a further incentive to...

Cromos pharma: international CRO

Cromos Pharma: International CRO

No Patients No Payment

No Patients No Payment

Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

FDA’s Real-Time Oncology Review

FDA’s Real-Time Oncology Review

Clinical research focus. 16th edition

Clinical research focus. 16th edition

Clinical Trials in the Baltic States

Clinical Trials in the Baltic States

Patient recruitment

Clinical Research Services

Regulatory Services

EU legal representation

Medical Writing

Data Management

CTM Logitics

PV Support

Independent Audits